PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Envigo appoints Chief Commercial Officer and President of EMEA Operations

The two new appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer experience for its global customer base across the pharmaceutical, chemicals, and crop protection industries. Both of the positions report directly into Dr. Adrian Hardy, Chief Executive Officer of Envigo.
Craig Boyd has joined Envigo in the position of Chief Commercial Officer.
Craig has more than 20 years’ experience in various global pharmaceutical markets and has worked extensively in the US, Asia, Europe and Australia. A dynamic commercial leader, Craig was the Executive Vice President of Mayne Pharma’s US specialty brands division before joining Envigo. Prior to this, Craig led the global commercial sales functions at Hospira and Mylan, and spent 10 years as a senior commercial sales and marketing executive at Novartis. In his new role, Craig is responsible for Envigo’s global commercial organization, including, sales, marketing, pricing and customer service activities.
Lizanne Muller has joined Envigo as President EMEA Operations.
Lizanne has 18 years’ experience working within a multinational pharmaceutical manufacturing company, and brings with her extensive commercial experience, specializing in operational finance, continuous improvements, regulatory compliance and change management. Prior to joining Envigo, Lizanne spent 16 years at the Dishman Group serving in a variety of roles of increasing responsibility including Vice President of Compliance and Governance. Lizanne is accountable for Envigo’s Contract Research Services and Research Services Models operations across Europe and Asia.
“I am delighted that Craig and Lizanne have joined the team at Envigo and both brought with them great experience and knowledge that has added huge value to the way we work”, commented Adrian Hardy. “Their experience and expertise will help us grow Envigo as we continue to focus on delighting our customers with great products and services. It’s a really exciting time at Envigo right now, with emphasis on enhancing our customers’ experience of working with us and cementing our presence as leaders in the markets we serve.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026